CD8A and neoplasm: Fernandez-Poma et al. [51] found that the expression of PD-1 on CD8+ TILs accurately defined the tumor-reactive cells and evaluated the antitumor activity of CD8+ PD-1+ TILs in vivo, which provide direct support for this notion.